United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Technology Industry News New CFO, interim CEO, and a shares-for-debt deal: What’s really going on at Hapbee Technologies? Hapbee Technologies (TSXV: HAPB) taps Krishna Subramanian as CFO and Riz Shah as interim CEO, signaling a leadership and financial realignment in wellness tech. byPallavi MadhirajuSeptember 15, 2025